Iran and China have launched a wide-ranging cooperation programme in the fields of pharmaceuticals, medical equipment, and healthcare supplies, the Iranian Food and Drug Administration (IFDA) announced this week.
The initiative is part of the two countries’ 25-year comprehensive cooperation agreement, which aims to deepen economic and technological ties.
Hamid Enanlou, IFDA’s Director of International Affairs, highlighted that the partnership covers multiple areas, including the transfer of pharmaceutical technology, joint drug production, and medical research.
“Part of this memorandum is dedicated to cooperation in the field of medicine, medical equipment and health supplies, and includes the transfer of pharmaceutical technology and knowledge, joint production of medicine, pharmaceutical research and the development of new medicines,” Enanlou said, according to Mehr News Agency.
The agreement also extends to the production and supply of medical devices and laboratory equipment, alongside the exchange of technology for syringes, diagnostic kits, and hygiene products. Plans involve joint investment, the establishment of new companies, and the training and exchange of specialized professionals.
Enanlou noted that IFDA has already taken steps to implement the initiative by building direct communication channels with Chinese institutions, facilitating the registration of health-focused products, and launching joint research and development platforms.
He added that the partnership is designed to support Iran’s domestic industry while also expanding opportunities in regional markets: “Part of this cooperation is aimed at strengthening domestic production and benefiting from regional markets for Iranian and Chinese companies.”
The joint health initiative reflects a broader trend of Iran and China expanding collaboration across strategic sectors, as Beijing continues to strengthen its role in the Middle East and Tehran seeks greater integration into Asian-led development frameworks.
